<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02683252</url>
  </required_header>
  <id_info>
    <org_study_id>RCB: 2015-A01604-45</org_study_id>
    <nct_id>NCT02683252</nct_id>
  </id_info>
  <brief_title>Musculoskeletal Non-tumoral Pathology Quantitative Perfusion</brief_title>
  <acronym>AFRONT</acronym>
  <official_title>Magnetic Resonance (MR) Imaging Quantitative Functional Perfusion Analysis of the Musculoskeletal System: Clinical Application in Non-tumoral Pathology</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Central Hospital, Nancy, France</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University Hospital, Lille</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Central Hospital, Nancy, France</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Study on quantitative perfusion parameters acquired on MR imaging of patients with
      non-tumoral pathology of the musculoskeletal system.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients referred for the MR imaging evaluation of non-tumoral musculoskeletal pathology
      (osteonecrosis, pseudarthrosis and compartment syndrome) will have their MR protocols
      complemented by a contrast enhanced perfusion study. In this patients standard clinical
      evaluation is already performed with contrast medium injection (Gadolinium) and no additional
      injection is required.

      After post processing multiple quantitative perfusions parameters will be extracted (e.g.
      plasmatic volume, transfer constant, backflow constant, extra-cellular extra vascular space
      volume). The variation of these parameters in patients with and without the previously
      described conditions will be compared.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>January 2016</start_date>
  <completion_date type="Anticipated">January 2020</completion_date>
  <primary_completion_date type="Anticipated">January 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Variation of the plasmatic volume estimation in the 5 study groups (arms) and between the images acquired in the two inclusion sites.</measure>
    <time_frame>3 years</time_frame>
    <description>The plasmatic volume (Vp%) in ml is a quantitative perfusion parameter that describes the capilar density of the tissues evaluated and can be useful in tissue characterization</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Variation of the plasma-extra-cellular space transfer contant in the 5 study groups (arms) and between the images acquired in the two inclusion sites.</measure>
    <time_frame>3 years</time_frame>
    <description>The plasma-extracellular space transfer constant (Ktrans) in min -1 is a quantitative perfusion parameter that is related to the capilar permeability and blood flow. This parameter can be useful for tissue characterization.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Variation of the extra-cellular space-plasma transfer contant (backflow constant) in the 5 study groups (arms) and between the images acquired in the two inclusion sites.</measure>
    <time_frame>3 years</time_frame>
    <description>The extracellular-space-plasma transfer constant or backflow constant (Kep) in min -1 is a quantitative perfusion parameter that is related to the capilar permeability. This parameter can be useful for tissue characterization.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Variation of the extra-cellular extra-vascular space volume in the 5 study groups (arms) and between the images acquired in the two inclusion sites.</measure>
    <time_frame>First 6 months of inclusion</time_frame>
    <description>The extracellular-space extra-vascular space volume (Ve%) in ml is a quantitative perfusion parameter that is related to the tissue cellularity. This parameter can be useful for tissue characterization.</description>
  </secondary_outcome>
  <number_of_arms>5</number_of_arms>
  <enrollment type="Anticipated">400</enrollment>
  <condition>Osteonecrosis</condition>
  <condition>Pseudarthrosis</condition>
  <condition>Compartment Syndrome</condition>
  <arm_group>
    <arm_group_label>Normal patients</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients with normal bone appearance on conventional MR images</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Carpal osteonecrosis</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients presenting signal anomalies compatible with osteonecrosis of the carpal bones on conventional MR images (hypointensity on T1 weighted sequences, no contrast enhancement).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Femoral head osteonecrosis</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients presenting signal anomalies compatible with osteonecrosis of the femroal head on conventional MR images (fat containing signal anomalies with geographic contours in the femoral epiphysis).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Pseudarthrosis</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients presenting a non consolidated macroscopic bone fracture for over 6 months (clinical history and imaging findings).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Compartment syndrome</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients with a confirmed compartment syndrome on intra-compartment pressure assessement</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>T1 mapping and MR perfusion acquisition</intervention_name>
    <description>One T1 mapping acquisition with variable flip angles will be performed before contrast injection. One perfusion 3D FSPGR sequence will be acquired after contrast injection</description>
    <arm_group_label>Normal patients</arm_group_label>
    <arm_group_label>Carpal osteonecrosis</arm_group_label>
    <arm_group_label>Femoral head osteonecrosis</arm_group_label>
    <arm_group_label>Pseudarthrosis</arm_group_label>
    <arm_group_label>Compartment syndrome</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  affiliation to a social security regimen

          -  Signature of an informed consent

          -  Clinical suspicion of one of the studied conditions (osteonecrosis of the wrist,
             osteonecrosis of the femoral head, pseudarthrosis and compartment syndrome)

        Exclusion Criteria:

          -  MR contraindications

          -  Contraindications to contrast injection

          -  Previous history of allergy to gadolinium containing contrast medium

          -  Presence of metallic hardware in the study zone

          -  Pregnancy

          -  Patients under tutelage
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Pedro TEIXEIRA, MD, PhD</last_name>
    <phone>33 (3) 83 85 21 61</phone>
    <email>ped_gt@hotmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Gabriela Hossu, PhD</last_name>
    <phone>33 (3) 83 15 50 96</phone>
    <email>g.hossu@chru-nancy.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Service d'Imagerie Guilloz, CHRU-Nancy</name>
      <address>
        <city>Nancy</city>
        <state>Lorraine</state>
        <zip>54000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alain Blum, MD, PhD</last_name>
      <phone>0033 3 83 85 21 61</phone>
      <email>alain.blum@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Pedro Teixeira, MD, PhD</last_name>
      <phone>0033 3 83 85 21 61</phone>
      <email>ped_gt@hotmail.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>CCIAL, CHRU-Lille</name>
      <address>
        <city>Lille</city>
        <state>Nord-pas-de-Calais</state>
        <zip>59036</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anne Cotten, MD, PhD</last_name>
      <phone>0033 3 20 44 59 62</phone>
      <email>Vanessa.vandendooren@CHRU-LILLE.FR</email>
    </contact>
    <contact_backup>
      <last_name>Guillaume Lefebvre, MD</last_name>
      <phone>0033 3 20 44 59 62</phone>
      <email>guillaume.lefebvre59@gmail.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <reference>
    <citation>Mueller D, Schaeffeler C, Baum T, Walter F, Rechl H, Rummeny EJ, Woertler K. Magnetic resonance perfusion and diffusion imaging characteristics of transient bone marrow edema, avascular necrosis and subchondral insufficiency fractures of the proximal femur. Eur J Radiol. 2014 Oct;83(10):1862-9. doi: 10.1016/j.ejrad.2014.07.017. Epub 2014 Jul 30.</citation>
    <PMID>25129825</PMID>
  </reference>
  <reference>
    <citation>Müller GM, Månsson S, Müller MF, Ekberg O, Björkman A. Assessment of perfusion in normal carpal bones with dynamic gadolinium-enhanced MRI at 3 Tesla. J Magn Reson Imaging. 2013 Jul;38(1):168-72. doi: 10.1002/jmri.23951. Epub 2012 Nov 27.</citation>
    <PMID>23188589</PMID>
  </reference>
  <reference>
    <citation>Bervian MR, Ribak S, Livani B. Scaphoid fracture nonunion: correlation of radiographic imaging, proximal fragment histologic viability evaluation, and estimation of viability at surgery: diagnosis of scaphoid pseudarthrosis. Int Orthop. 2015 Jan;39(1):67-72. doi: 10.1007/s00264-014-2579-4. Epub 2014 Nov 16.</citation>
    <PMID>25398469</PMID>
  </reference>
  <reference>
    <citation>Rominger MB, Lukosch CJ, Bachmann GF. MR imaging of compartment syndrome of the lower leg: a case control study. Eur Radiol. 2004 Aug;14(8):1432-9. Epub 2004 Apr 6.</citation>
    <PMID>15067424</PMID>
  </reference>
  <results_reference>
    <citation>Teixeira PA, Chanson A, Beaumont M, Lecocq S, Louis M, Marie B, Sirveaux F, Blum A. Dynamic MR imaging of osteoid osteomas: correlation of semiquantitative and quantitative perfusion parameters with patient symptoms and treatment outcome. Eur Radiol. 2013 Sep;23(9):2602-11. doi: 10.1007/s00330-013-2867-1. Epub 2013 May 22.</citation>
    <PMID>23695220</PMID>
  </results_reference>
  <verification_date>January 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 28, 2016</study_first_submitted>
  <study_first_submitted_qc>February 11, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 17, 2016</study_first_posted>
  <last_update_submitted>February 11, 2016</last_update_submitted>
  <last_update_submitted_qc>February 11, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 17, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Magnetic resonance imaging</keyword>
  <keyword>perfusion</keyword>
  <keyword>quantitative</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteonecrosis</mesh_term>
    <mesh_term>Compartment Syndromes</mesh_term>
    <mesh_term>Pseudarthrosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

